Risk Assessment Tool

Colon cancer risk assessment

Colon cancer is a very common, yet highly preventable, disease. You can reduce your risk for developing colon cancer by maintaining a healthy lifestyle and beginning routine colonoscopy screening at age 50, or earlier if you have certain risk factors. Take the quiz to assess whether you have certain risk factors for colon cancer and learn what you can do to minimize that risk. This is meant to be a guide, rather than a diagnostic tool, and should not replace consultation with your healthcare provider.

Measuring progress

The orange tabs represent the number of risk factors for colon cancer. This number neither confirms nor denies the likelihood of a future diagnosis of colon cancer. It simply indicates that certain aspects of your life could increase your risk.

  • Question 1
  • Question 2
  • Question 3
  • Question 4
  • Question 5
  • Question 6
  • Question 7
  • Question 8
  • Question 9
  • Results
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

Questions and risk explanation

Age

Are you 50 years of age or older (45 or older for African Americans)?

Next Question

Your risk for developing colon cancer dramatically increases with age; 9 out of 10 people affected are aged 50 years or older.1 You should receive routine colon screenings starting at age 50 and be screened once every 10 years after that. If you have other risk factors, your doctor may recommend more frequent screenings.

Colon cancer risk assessment results

The results of your assessment are listed below. This is meant to be a guide, rather than a diagnostic tool, and should not replace consultation with your healthcare provider.

Question 1

Question 2

Question 3

Question 4

Question 5

Question 6

Question 7

Question 8

Question 9

Print results

 of 9 risk factors. You have indicated  risk factors for colon cancer. This number neither confirms nor denies the likelihood of a future diagnosis of colon cancer. It simply indicates that certain aspects of your life could increase you risk.

Take charge of your health. Empower yourself and spread awareness about the prevention and detection of colorectal cancer. Join the MoviMent.

Join The Moviment - Sign up to download the My Moviment Prep Kit and share your story.
My Moviment

Important Safety Information about MOVIPREP

MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. MOVIPREP is contraindicated in patients with gastrointestinal (GI) obstruction, bowel perforation, gastric retention, ileus, toxic colitis or toxic megacolon, and patients who have had a severe hypersensitivity reaction to any of its components. MOVIPREP should be used with caution in patients at risk of or with fluid and electrolyte abnormalities, hyponatremia, arrhythmias, seizures, in patients with impaired renal function or patients taking concomitant medications that affect renal function, patients with known or suspected inflammatory bowel disease, patients with suspected GI obstruction or perforation, patients at risk for aspiration, and patients with glucose-6-phosphate dehydrogenase deficiency. Most common adverse reactions for split dosing (incidence ≥5%) are malaise, nausea, abdominal pain, vomiting, and upper abdominal pain. The most common adverse reactions for evening only dosing (incidence ≥5%) are abdominal distension, anal discomfort, thirst, nausea, abdominal pain, sleep disorder, rigors, hunger, malaise, vomiting, and dizziness. MOVIPREP contains 233 mg of phenylalanine per treatment. Advise patients to hydrate adequately before, during, and after the use of MOVIPREP.

You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/safety/medwatch/ or call 1-800-FDA-1088.

Complete Prescribing Information pdf icon

References: 1. Colon cancer. Mayo Clinic Web site. Available at: http://www.mayoclinic.com/health/colon-cancer/DS00035. Accessed May 18, 2011. 2. Tomeo CA, Colditz GA, Willett WC, et al. Harvard report on cancer prevention. Volume 3: Prevention of colon cancer in the United States. Cancer Causes Control. 1999;10:167-180.